When.com Web Search

  1. Ads

    related to: cologuard positive for colon cancer

Search results

  1. Results From The WOW.Com Content Network
  2. New colorectal cancer blood test approved by FDA: What to know

    www.aol.com/colorectal-cancer-blood-test...

    It has a false negative rate of 13% and a false positive rate of roughly 10%. It detects 13% of advanced colon adenomas, which are the precursors to colorectal cancer.” ... Cologuard, and ...

  3. What Is the Age Limit for Medicare Coverage of Cologuard?

    www.aol.com/age-limit-medicare-coverage...

    Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. ... or any type of positive result on either a urine or blood ...

  4. Is there an age limit for Cologuard through Medicare?

    www.aol.com/age-limit-cologuard-medicare...

    Cologuard refers to an at-home stool DNA test that can help screen for colon cancer or polyps.A person enrolled in Medicare aged between 45 and 85 is eligible for coverage for a Cologuard test ...

  5. Dreading a colonoscopy? There are alternatives | Savvy Senior

    www.aol.com/dreading-colonoscopy-alternatives...

    While a colonoscopy remains the most accurate screening test for detecting colon cancer, there are other easier — but less accurate — tests available. ... (Cologuard): This screening kit looks ...

  6. Colorectal cancer - Wikipedia

    en.wikipedia.org/wiki/Colorectal_cancer

    Colorectal cancer (CRC), also known as bowel cancer, colon cancer, or rectal cancer, is the development of cancer from the colon or rectum (parts of the large intestine). [5] Signs and symptoms may include blood in the stool , a change in bowel movements , weight loss, abdominal pain and fatigue. [ 9 ]

  7. Exact Sciences Corp. - Wikipedia

    en.wikipedia.org/wiki/Exact_Sciences_Corp.

    Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.